SCHEMBL4768434

SCHEMBL4768434

O=C(O)C1(c2ccsc2)CCC2(CC1)OCCO2

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKR1C1 Q04828 1/20 0.38
HCAR3 P49019 1/20 0.37
HCAR2 Q8TDS4 1/20 0.37
ALDH1A1 P00352 2/20 0.35
LCK P06239 1/20 0.33
FYN P06241 1/20 0.33
DAO P14920 1/20 0.33
KCNA3 P22001 1/20 0.33
RAB9A P51151 3/20 0.33
SMN1; SMN2 Q16637 3/20 0.33
NPC1 O15118 2/20 0.33
MEN1 O00255 2/20 0.33
KMT2A Q03164 2/20 0.33
MAPK1 P28482 1/20 0.33
CASP1 P29466 1/20 0.33
CASP7 P55210 1/20 0.33
HSD17B10 Q99714 1/20 0.33
HPGD P15428 1/20 0.33
L3MBTL1 Q9Y468 2/20 0.32
APP P05067 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2794298 0.87 AKR1C1 (0.47) AKR1C1HCAR3HCAR2LCKFYN
SCHEMBL14258205 0.81 AKR1C1 (0.42) AKR1C1HCAR3HCAR2LCKFYN
SCHEMBL8110728 0.80 AKR1C1 (0.58) AKR1C1HCAR3HCAR2LCKFYN
SCHEMBL8112526 0.80 AKR1C1 (0.53) AKR1C1HCAR3HCAR2LCKFYN
SCHEMBL735386 0.79 AKR1C1 (0.61) AKR1C1ALDH1A1RAB9ASMN1; SMN2NPC1
SCHEMBL2874416 0.79 AKR1C1 (0.56) AKR1C1HCAR3HCAR2LCKFYN
SCHEMBL4768442 0.78 HCAR3 (0.35) HCAR3HCAR2ALDH1A1LCKFYN
SCHEMBL3219496 0.75 APP (0.50) AKR1C1RAB9ANPC1KMT2AAPP
SCHEMBL28018276 0.75 CES2 (0.40) HCAR3HCAR2LCKFYNDAO
SCHEMBL3924857 0.73 ALDH1A1 (0.49) ALDH1A1KMT2AGAAPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1725567-B1 SPIROCYCLIC CYCLOHEXANE DERIVATIVES WITH AFFINITY TO THE ORL-1 RECEPTOR GRUENENTHAL GMBH (DE) 2008-03-26 EP disclosed
US-7332519-B2 Spirocyclic cyclohexane compounds GRUENENTHAL GMBH (DE) 2008-02-19 US disclosed
EP-1725567-A1 SPIROCYCLIC CYCLOHEXANE DERIVATIVES WITH AFFINITY TO THE ORL-1 RECEPTOR Grünenthal GmbH (DE) 2006-11-29 EP disclosed
US-20050192333-A1 Spirocyclic cyclohexane compounds GRUENENTHAL GMBH (DE) 2005-09-01 US disclosed
WO-2005066183-A1 SPIROCYCLIC CYCLOHEXANE DERIVATIVES WITH AFFINITY FOR THE ORL1-RECEPTOR Grünenthal GmbH (DE) 2005-07-21 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050192333-A1 Spirocyclic cyclohexane compounds OPRL1, OPRK1, OPRD1 AKR1C1 718/4885HCAR3 163/4885HCAR2 26/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.